These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33785365)

  • 1. Early T-Cell Precursor Acute Lymphoblastic Leukemia and T/Myeloid Mixed Phenotype Acute Leukemia Possess Overlapping Characteristics and Both Benefit From CAG-Like Regimens and Allogeneic Hematopoietic Stem Cell Transplantation.
    Liu S; Cui Q; Dai H; Song B; Cui W; Xue S; Qiu H; Miao M; Jin Z; Li C; Fu C; Wang Y; Sun A; Chen S; Zhu X; Wu D; Tang X
    Transplant Cell Ther; 2021 Jun; 27(6):481.e1-481.e7. PubMed ID: 33785365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia].
    Zhu YX; Zhu MQ; Dai HP; Liu SN; Yin J; Li Z; Cui QY; Zhu XM; Wu DP; Tang XW
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1021-1025. PubMed ID: 32023734
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
    Luo L; Jiao Y; Li Y; Yang P; Gao J; Huang S; Huang W; Wang J; Dong F; Ke X; Zou D; Gao C; Jing H
    Ann Hematol; 2024 Jun; 103(6):2073-2087. PubMed ID: 38581546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
    Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
    Front Immunol; 2021; 12():605766. PubMed ID: 34025637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Yasuda S; Najima Y; Konishi T; Yamada Y; Nagata A; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Shingai N; Yoshioka K; Inamoto K; Mukae J; Toya T; Igarashi A; Shimizu H; Kobayashi T; Kakihana K; Sakamaki H; Kawamata N; Ohashi K; Doki N
    Leuk Res; 2021 Sep; 108():106627. PubMed ID: 34062327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia.
    Meng T; Qi J; Zhu Y; Xu Y; Chen F; Xue S; Miao M; Chen S; Han Y; Tang X; Qiu H; Sun A; Wu D; Wang Y
    Hematol Oncol; 2021 Aug; 39(3):358-363. PubMed ID: 33521954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Characteristics of Patients with Ph
    Jia YN; Li Y; Gong XY; Liu KQ; Ye L; Wang HJ; Li QH; Li CW; Wang Y; Wang JX; Mi YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):354-359. PubMed ID: 30998137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review.
    Zhao Y; Jiang S; Tang Y; Zhao L
    Int J Hematol; 2023 Oct; 118(4):483-488. PubMed ID: 37269505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy.
    Yang TT; Meng Y; Kong DL; Wei GQ; Zhang MM; Wu WJ; Shi JM; Luo Y; Zhao YM; Yu J; Jing RR; Zhao MY; Zhao HL; Huang H; Hu YX
    Front Immunol; 2022; 13():934442. PubMed ID: 36110859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
    Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y
    J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
    Yoon JH; Kim HS; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Lee JW; Kim M; Kim Y; Lee S
    Eur J Haematol; 2023 Feb; 110(2):137-148. PubMed ID: 36217591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Philadelphia Chromosome Karyotype and Allogeneic Hematopoietic Stem Cell Transplantation on Patients with Acute Lymphoblastic Leukemia].
    Wang Y; Xu XM; Zhang M; Wang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1397-1406. PubMed ID: 36208241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allogeneic hematopoietic stem cell transplantation in acute leukemia patients with the SET-NUP214 fusion gene: Efficacy and survival analysis].
    Xia J; Zhao Y; Chen F; Miao M; Qiu HY; Ma X; Tang XW; Wang Y; Wu XJ; Fu ZZ; Wu DP; Chen SN
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):410-415. PubMed ID: 37032136
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
    Lazzarotto D; Tanasi I; Vitale A; Piccini M; Dargenio M; Giglio F; Forghieri F; Fracchiolla N; Cerrano M; Todisco E; Papayannidis C; Leoncin M; Defina M; Guolo F; Pasciolla C; Delia M; Chiusolo P; Mulè A; Candoni A; Bonifacio M; Pizzolo G; Foà R
    Ann Hematol; 2023 May; 102(5):1099-1109. PubMed ID: 36959485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases.
    Takahashi Y; Kaimi Y; Taniguchi H; Ochi T; Makino H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K; Maeshima AM
    Hum Pathol; 2024 Aug; 150():78-85. PubMed ID: 38945375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.